APN News

  • Wednesday, August, 2020| Today's Market | Current Time: 01:32:36
  • Wipro Helps Launch New Clinical Drugs Faster and Safer

    Published on October 6, 2010

    Bangalore,India : Wipro Technologies the global Consulting, System Integration and Outsourcing business of Wipro Limited  today announced the launch of Wipro Rapid Trials platform to accelerate drug development across the globe.
    The Wipro Rapid Trials platform is based on the Oracle Life Sciences software suite of products which is an open standards-based platform for business process integration across drug development life cycle. The platform improves data collection speed and quality by creating a cost effective and secure worldwide infrastructure (based on ISO 9001 and ISO27001 standards). This will enable organizations to conduct global trials without having to worry about IT infrastructure challenges. Wipro provides business process outsourcing services including clinical operations support and managed IT infrastructure to allow clients to achieve their clinical research and development benchmarks.
    Furthermore the platform cuts the total cost of ownership by 30-40% as the resources are shared across trials while guaranteeing the highest data security possible, all without having to maintain in-house capital equipment, clinical operations.
    Working with Oracle, Wipro has deployed a complete end-to-end clinical development environment which allows their clients to rapidly utilize the platform on a trial-by-trial or a specific time-based pricing model. This unique offering presents a great opportunity to small and mid-sized pharmaceutical sponsors and Contract Research Organizations (CROs) needing to standardize their clinical data collection process and operational parameters across studies and regions without having to compromise on quality. Wipro is now able to on-board new clients in as little as ten weeks with this model as against eight to twelve months earlier.
    “Many enterprises find themselves challenged to deliver and standardize Electronic Data Management and Data Capture processes across their partner channels that often span multiple geographies,” said Neil de Crescenzo, Senior Vice President & General Manager, Oracle’s Health Sciences Global Business Unit. “Leveraging Oracle products, like Oracle Clinical, Oracle Remote Data Capture, and Oracle Thesaurus Management System combined with its industry expertise, Wipro is very well positioned to deliver clinical trial services.”
    NS Bala, Senior Vice President, Manufacturing & Life Sciences Business Unit, Wipro Technologies said, “This agreement is part of our continued strategy to invest in industry based solutions, innovation and build deep industry expertise along with partners such as Oracle, Pharmasol and Icon Technical Group Inc. The Wipro Rapid Trials solution is developed and designed to maximize the return on investment to the sponsors and provide faster time to market to help them develop drugs faster and safer”.

    Bangalore,India :Wipro Technologies the global Consulting, System Integration and Outsourcing business of Wipro Limited (NYSE:WIT) today announced the launch of Wipro Rapid Trials platform to accelerate drug development across the globe.
    The Wipro Rapid Trials platform is based on the Oracle Life Sciences software suite of products which is an open standards-based platform for business process integration across drug development life cycle. The platform improves data collection speed and quality by creating a cost effective and secure worldwide infrastructure (based on ISO 9001 and ISO27001 standards). This will enable organizations to conduct global trials without having to worry about IT infrastructure challenges. Wipro provides business process outsourcing services including clinical operations support and managed IT infrastructure to allow clients to achieve their clinical research and development benchmarks.
    Furthermore the platform cuts the total cost of ownership by 30-40% as the resources are shared across trials while guaranteeing the highest data security possible, all without having to maintain in-house capital equipment, clinical operations.
    Working with Oracle, Wipro has deployed a complete end-to-end clinical development environment which allows their clients to rapidly utilize the platform on a trial-by-trial or a specific time-based pricing model. This unique offering presents a great opportunity to small and mid-sized pharmaceutical sponsors and Contract Research Organizations (CROs) needing to standardize their clinical data collection process and operational parameters across studies and regions without having to compromise on quality. Wipro is now able to on-board new clients in as little as ten weeks with this model as against eight to twelve months earlier.
    “Many enterprises find themselves challenged to deliver and standardize Electronic Data Management and Data Capture processes across their partner channels that often span multiple geographies,” said Neil de Crescenzo, Senior Vice President & General Manager, Oracle’s Health Sciences Global Business Unit. “Leveraging Oracle products, like Oracle Clinical, Oracle Remote Data Capture, and Oracle Thesaurus Management System combined with its industry expertise, Wipro is very well positioned to deliver clinical trial services.”
    NS Bala, Senior Vice President, Manufacturing & Life Sciences Business Unit, Wipro Technologies said, “This agreement is part of our continued strategy to invest in industry based solutions, innovation and build deep industry expertise along with partners such as Oracle, Pharmasol and Icon Technical Group Inc. The Wipro Rapid Trials solution is developed and designed to maximize the return on investment to the sponsors and provide faster time to market to help them develop drugs faster and safer”.

    Loading...